Evidence map›Paper›PMID 42847005›Full record

ArticleRSC applied polymers2026

Combinatorial synthesis of novel polycations for mRNA delivery

Lewis O'Shaughnessy, Rahman Khosravi, Akosua Anane-Adjei, Mariarosa Mazza, Naoto Hori, Pratik Gurnani, Cameron Alexander

Abstract read
In one paragraph

Article in RSC applied polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lewis O'ShaughnessyDivision of Molecular Therapeutics and Formulation, Boots Science Building, School of Pharmacy, University of Nottingham Nottingham NG7 2RD UK cameron.alexander@nottingham.ac.uk.ORCID https://orcid.org/0009-0002-1238-4016
Rahman KhosraviDivision of Molecular Therapeutics and Formulation, Boots Science Building, School of Pharmacy, University of Nottingham Nottingham NG7 2RD UK cameron.alexander@nottingham.ac.uk.
Akosua Anane-AdjeiAdvanced Drug Delivery, Pharmaceutical Sciences, Biopharmaceuticals R&D, AstraZeneca Cambridge UK.ORCID https://orcid.org/0000-0003-1192-6290
Mariarosa MazzaAdvanced Drug Delivery, Pharmaceutical Sciences, Biopharmaceuticals R&D, AstraZeneca Cambridge UK.
Naoto HoriDivision of Molecular Therapeutics and Formulation, Boots Science Building, School of Pharmacy, University of Nottingham Nottingham NG7 2RD UK cameron.alexander@nottingham.ac.uk.ORCID https://orcid.org/0000-0003-0658-8266
Pratik GurnaniUCL School of Pharmacy, University College London 29-39 Brunswick Square Bloomsbury London WC1N 1AX UK p.gurnani@ucl.ac.uk.ORCID https://orcid.org/0000-0002-6559-5514
Cameron AlexanderDivision of Molecular Therapeutics and Formulation, Boots Science Building, School of Pharmacy, University of Nottingham Nottingham NG7 2RD UK cameron.alexander@nottingham.ac.uk.ORCID https://orcid.org/0000-0001-8337-1875

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA therapeutics offer solutions to treat previously undruggable diseases, but successful RNA delivery requires efficient and safe vectors. Cationic polymers provide one technology platform for this delivery, however, despite many current materials in this class showing promise when tested in cells, none have yet progressed to the clinic. Existing commercially available polymers evaluated for RNA delivery have either limited structural variety or poorly addressable functionality, which means that tuning of pharmaceutical properties is difficult. In order to control better some parameters of key importance for RNA delivery, such as assembly with nucleic acids, internalisation into target cells and degradation after payload release, new chemistries and structures are needed. Multicomponent polymerisations provide a means to access easily highly functionalised materials, thus here we report the use of Ugi 4-component polymerisation to synthesise a range of cationic polyamides. We demonstrate a facile synthetic route to a diverse polymer library which, when screened for

Identifiers

PMID42847005
PMCPMC13644684

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.